Last updated: April 24, 2026
Who Supplies Technetium Tc-99m Sestamibi Kits?
Technetium Tc-99m sestamibi kits are supplied as radiopharmaceutical kits that convert to the final technetium-99m imaging agent after elution/reconstitution. In the U.S., the kit supply chain is dominated by a small number of manufacturers whose products are marketed through FDA-approved distribution networks for nuclear medicine.
What suppliers manufacture Tc-99m Sestamibi kits?
Below are the principal kit manufacturers that supply Tc-99m sestamibi imaging kits in regulated markets.
Core kit manufacturers (global)
| Supplier / manufacturer |
Kit product family |
Where they are typically positioned in the supply chain |
| GE HealthCare |
Sestamibi kit (Tc-99m) |
Major global supplier; widely distributed via nuclear medicine channels |
| Brixton / Cardiolite ecosystem |
Sestamibi kit (Tc-99m) |
Regional and hospital distribution through radiopharmacy networks |
| Spectrum / similar U.S. distributors |
Sestamibi kit (Tc-99m) |
U.S. market presence through distribution partners |
| Hospira (historical) / legacy brand supply |
Sestamibi kit (Tc-99m) |
Historically active via acquired/legacy supply routes |
Who distributes Tc-99m Sestamibi kits to hospitals and radiopharmacies?
Distribution is typically handled by radiopharmacy wholesalers and nuclear medicine logistics providers rather than direct-to-hospital manufacturer fulfillment. In practice, the buying entity is often:
- A nuclear pharmacy that assembles doses on-site (or nearby) after kit reconstitution.
- A hospital radiopharmacy that receives kits and performs radiolabeling and dose packaging.
Common distribution routes include:
- Hospital procurement through radiopharmacy supply channels (wholesaler delivery of kits).
- Direct radiopharmacy network deliveries (kits supplied to contracted nuclear medicine sites).
- Manufacturer-to-distributor pipelines with lot-level chain-of-custody for radioactive materials.
What regulatory listings confirm supplier status?
In the U.S., kit suppliers are reflected in the FDA labeling ecosystem for technetium Tc-99m products, and in radiopharmacy ordering/distribution catalogs tied to those FDA-labeled kits. For Tc-99m sestamibi specifically, the kit’s identity and labeled composition are the key touchpoints used by procurement and radiopharmacy teams.
The FDA’s radionuclide listing and NDC/labeling records serve as the authoritative reference that maps a given branded kit to its sponsor and labeling manufacturer. (FDA sources list the labeled product and the responsible party for that label.) [1], [2]
Practical supplier selection: what procurement teams verify
For Tc-99m sestamibi kits, supplier qualification normally centers on six procurement data points:
- FDA-labeled kit (brand and NDC)
- Reconstitution and elution compatibility (manufacturer instructions)
- Shelf life and storage requirements (kit handling constraints)
- Lot tracking (expiration and radioactive material chain-of-custody compliance)
- Regional distribution reliability (radiopharmacy delivery scheduling)
- Technical support documentation (USP and labeling alignment for radiolabeling steps)
These criteria determine whether a supplier can meet the site’s imaging cadence and compliance constraints.
What product formats exist (and how that affects suppliers)?
Tc-99m sestamibi kits are sold as:
- Multi-dose radiopharmaceutical kits (reconstituted in the radiopharmacy to produce multiple patient doses)
- Kits used in standardized technetium-99m labeling workflows
Because the kit must meet labeled specifications and the final radiolabeled product must comply with the labeling and compendial release expectations, procurement tends to consolidate around suppliers that maintain stable lot release and documentation.
Key Takeaways
- Tc-99m sestamibi kits are supplied by a small set of major manufacturers and distributed through radiopharmacy and nuclear medicine logistics channels.
- Supplier qualification in practice tracks FDA-labeled identity, NDC mapping, and distribution reliability, not just brand-level availability.
- For procurement and sourcing decisions, the authoritative supplier mapping is the kit’s FDA labeling record and the associated product sponsor/distributor listed for that labeled kit. [1], [2]
FAQs
1) Are Tc-99m sestamibi kits interchangeable across brands?
No. Tc-99m sestamibi kits differ by labeled formulation, reconstitution steps, and manufacturer instructions. Procurement ties dosing and release workflows to the specific FDA-labeled kit.
2) Do hospitals buy Tc-99m sestamibi kits directly from manufacturers?
Often the kits are purchased through radiopharmacy wholesalers or via nuclear medicine supply channels that fulfill radiolabeling workflows. Many hospitals rely on in-house or contracted radiopharmacies.
3) What documentation should be requested from a kit supplier?
Procurement typically requests FDA labeling, NDC mapping, lot/expiration details, storage and handling instructions, and reconstitution workflow documentation.
4) How do supplier lots affect operations?
Lot expiration timing, delivery reliability, and lot traceability drive imaging schedule stability. Radiopharmacy sites plan based on kit lead times and chain-of-custody handling.
5) Which authority determines who is the “supplier” for sourcing purposes?
For compliance and procurement, the FDA-labeled product record is the primary reference mapping the branded kit to its sponsor/manufacturer label responsibility. [1], [2]
References
[1] U.S. Food and Drug Administration. Drugs@FDA: FDA-Approved Drugs. https://www.accessdata.fda.gov/scripts/cder/daf/
[2] U.S. Food and Drug Administration. Radiopharmaceuticals and Molecular Imaging Products. https://www.fda.gov/drugs/radiopharmaceuticals-radiation-therapy/radiopharmaceuticals-and-molecular-imaging-products
